Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study34

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study19

Views

Views
October 20240
November 20240
December 20242
January 20251
February 20252
March 202514
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States3
United Kingdom2
 

Top cities views

Views
Dallas1
Lombard1